Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

600 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Recruiting

Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa

NCT06940830

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Sobi Investigational Site Zagreb, Croatia
  • Sobi Investigational Site Brno, Czechia
  • Sobi Investigational Site Ostrava, Czechia
  • Sobi Investigational Site Prague, Czechia
View all 29 locations
View Trial Details
Recruiting

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

NCT06716814

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +16 more
Locations
  • Sobi Investigational Site Plovdiv, Bulgaria
  • Sobi Investigational Site Sofia, Bulgaria
  • Sobi Investigational Site Brest, France
  • Sobi Investigational Site Bron, France
View all 21 locations
View Trial Details
Recruiting

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

NCT07285460

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • The Luskin Orthopaedic Institute for Children- Site Number : 8400013 Los Angeles, California, United States
  • The Center for Inherited Blood Disorders- Site Number : 8400009 Orange, California, United States
  • Cure 4 The Kids Foundation- Site Number : 8400001 Las Vegas, Nevada, United States
  • Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400008 Hackensack, New Jersey, United States
View all 30 locations
View Trial Details
Recruiting

Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand Treatment

NCT07663903

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China
  • Fuyang Hospital, Affiliated to Anhui Medical University Fuyang, China
  • Fujian Medical University Union Hospital Fuzhou, China
  • Ganzhou People's Hospital Ganzhou, China
View all 24 locations
View Trial Details
Recruiting

Lentiviral FVIII Gene Therapy

NCT03217032

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China
View Trial Details
Recruiting

An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency

NCT07644832

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +9 more
Locations
  • Xiangya Hospital of Central South University Changsha, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, China
  • Jinan Central Hospital Jinan, China
  • The First Hospital of Lanzhou University Lanzhou, China
View Trial Details
Recruiting

A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

NCT06703606

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Orthopaedic Institute for Children/Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • Brody School of Medicine at East Carolina University Greenville, North Carolina, United States
  • ECU Health Medical Center Greenville, North Carolina, United States
  • Nirmal Hospital Pvt Ltd. Surat, Gujarat, India
View Trial Details
Recruiting

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

NCT05568719

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
Locations
  • The Regents of the University of California||UC Davis Health Rancho Cordova, California, United States
  • UC Davis Health Sacramento, California, United States
  • UC Davis Ambulatory Care Clinic Sacramento, California, United States
  • UC Davis Hemophilia Treatment Center Sacramento, California, United States
View all 23 locations
View Trial Details

Related conditions